RC Medical is positioning itself as a different kind of medical device company, one that begins with the clinical problem rather than the engineering idea. The Lake Forest, California-based venture studio funds, designs, develops, and commercializes products for the interventional radiology market by partnering directly with physician-entrepreneurs and forming a standalone company around each validated concept.
The distinction matters because most device companies, according to CEO David Ferrera, start with an engineer's idea and then search for a clinical problem to fit it. RC Medical inverts that sequence. "We go to the interventional suite first," Ferrera said. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing."
The implications extend beyond how products are conceived. Under the studio model, a physician who brings an idea forward does not hand it off and wait for a report. Ferrera describes the relationship as a partnership running from the first sketch through commercialization, with the physician staying close to the clinical need while RC Medical manages product development, funding, regulatory strategy, and the business structure required to bring a device to market.
When an idea clears the studio's early evaluation, RC Medical does not fold it into an existing product line. It creates a new company with its own team and focus. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to," Ferrera said. That structure has already produced three separate companies out of the studio: Single Pass, Infinity Neuro, and Sonorous NV. Each grew out of a specific problem a physician described in the interventional suite, and each operates as an independent business rather than a division of RC Medical.
Ferrera argues this structure suits interventional radiology in particular. He has spent close to three decades building devices for interventional neuroradiology and related fields, including co-founding Blockade Medical and serving as Chief Technology Officer of Balt Global. The lesson he carries into RC Medical is that physicians in these procedures see problems that never make it into a traditional product roadmap. "A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he said. "That detail doesn't show up unless you're building with the physician, not for them." Catching such details early, before a device design is locked in and difficult to change, is central to the model's rationale.
Ferrera is also candid that the studio is not the right fit for every idea. "Some ideas are better as a feature of an existing product, not a new company," he said. "Part of the first conversation is being honest about which one this is." For ideas that do become new companies, physician involvement typically continues through development and toward the market, keeping the clinical need in view at every stage rather than only at the outset.
For the interventional radiology field, the studio's significance lies in its attempt to shorten the distance between what physicians observe in practice and what device developers choose to build, a gap Ferrera contends conventional product planning routinely leaves unaddressed.
